Nrf2 activator (Xuzhou Medical University)

N/A

Report date: 2025/03/20 09:57:07
NME

Base Information

Drug NameNrf2 activator (Xuzhou Medical University)
Drug Alias Namedaphnoretin-7-O-beta-D-glucopyranoside
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 stimulants
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXuzhou Medical University (Xzmu)
China Registration ClassN/A

Develop Information

Active CompaniesXuzhou Medical University (Xzmu)
Inactive CompaniesN/A
Active IndicationsDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A